Sabashini K Ramchand

10PUBLICATIONS
11CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Orthodontics and dentofacial orthopaedicsOrthopticsBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 23, 2025
Comparative bone histomorphometry effects of combined denosumab and teriparatide vs monotherapy in postmenopausal women with osteoporosis: a randomized controlled trial.

Sabashini K Ramchand, Joy N Tsai, Yingshe Zhao

|Jul 02, 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial.

Sabashini K Ramchand, Ali Ghasem-Zadeh, Rudolf Hoermann

|Jan 05, 2024
Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT.

Sabashini K Ramchand, Rudolf Hoermann, Shane White

|Oct 05, 2023
The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.

Sabashini K Ramchand, Joy N Tsai, Hang Lee

|Nov 05, 2022
The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.

Sabashini K Ramchand, Natalie L David, Hang Lee

|Jan 28, 2021
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.

Sabashini K Ramchand, Natalie L David, Hang Lee

Pageof 2